Investor Relations

Since 1996, Zynex Medical has been a leading provider of relief for patients with functional disability through the creation, distribution and marketing of the highest quality electrotherapy products available today. Our mission is one of commitment, a passion for innovation and a dedication to the health of patients that we serve. Since going public in early 2004, we are highly dedicated and committed to developing stable, mutually satisfying relationships with our shareholders. Zynex Medical is a publicly traded company trading under the symbol ZYXI on Nasdaq otc.bb. For current Stock prices see Nasdaq.com.

Zynex Medical has established a solid business base in several areas:

Scientifically Tested, FDA Approved
Backed by years of scientific evidence and testing, all products manufactured and sold by Zynex Medical are supported by a wealth of results driven research and are generally accepted throughout the medical community as a key component in an integrated rehabilitation program. All products manufactured and sold by Zynex Medical have been cleared by the Food and Drug Administration for sale in the US.

Global Distribution
Zynex Medical’s products are sold throughout the United States and through a network of regional distributors world-wide.

Proven Sales and Business Plan
Zynex medical promotes our standard electrotherapy products to physicians through a direct sales force as well as various marketing tools targeted to both the consumer and the specialized practitioners. Through patient prescriptions, our products are distributed to those in need, who will be billed via private insurance or Medicare.

A Focus on Cost Savings
Zynex Medical’s innovative product line are proven to significantly reduce patient rehabilitation time and create a higher level of patient mobility and independence which leads to fewer accidents and less hospitalization. This also helps reduce the need for expensive support equipment and costly medical assistance.

Zynex Medical has established a specialized team focused on Investor Relations to assure quality service and satisfactory return for all investors. For more information please contact: